1726 related articles for article (PubMed ID: 29895977)
1. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.
Shi Y; Wang Y; Li Q; Liu K; Hou J; Shao C; Wang Y
Nat Rev Nephrol; 2018 Aug; 14(8):493-507. PubMed ID: 29895977
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
Markov A; Thangavelu L; Aravindhan S; Zekiy AO; Jarahian M; Chartrand MS; Pathak Y; Marofi F; Shamlou S; Hassanzadeh A
Stem Cell Res Ther; 2021 Mar; 12(1):192. PubMed ID: 33736695
[TBL] [Abstract][Full Text] [Related]
4. The Immunomodulatory Potential of Mesenchymal Stem Cells in a Retinal Inflammatory Environment.
Hermankova B; Kossl J; Bohacova P; Javorkova E; Hajkova M; Krulova M; Zajicova A; Holan V
Stem Cell Rev Rep; 2019 Dec; 15(6):880-891. PubMed ID: 31863334
[TBL] [Abstract][Full Text] [Related]
5. Current understanding of the immunosuppressive properties of mesenchymal stromal cells.
de Castro LL; Lopes-Pacheco M; Weiss DJ; Cruz FF; Rocco PRM
J Mol Med (Berl); 2019 May; 97(5):605-618. PubMed ID: 30903229
[TBL] [Abstract][Full Text] [Related]
6. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
Front Immunol; 2018; 9():1078. PubMed ID: 29892282
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.
Huang Y; Wu Q; Tam PKH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077421
[TBL] [Abstract][Full Text] [Related]
8. The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus.
Zhu L; Wang S; Qu J; Hui Z; Kan C; Hou N; Sun X
Cell Reprogram; 2022 Dec; 24(6):329-342. PubMed ID: 35877064
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
10. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.
Ling W; Zhang J; Yuan Z; Ren G; Zhang L; Chen X; Rabson AB; Roberts AI; Wang Y; Shi Y
Cancer Res; 2014 Mar; 74(5):1576-87. PubMed ID: 24452999
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease.
Yang H; Cheong S; He Y; Lu F
Stem Cell Res Ther; 2023 Dec; 14(1):372. PubMed ID: 38111001
[TBL] [Abstract][Full Text] [Related]
13. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
14. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.
Ren G; Su J; Zhang L; Zhao X; Ling W; L'huillie A; Zhang J; Lu Y; Roberts AI; Ji W; Zhang H; Rabson AB; Shi Y
Stem Cells; 2009 Aug; 27(8):1954-62. PubMed ID: 19544427
[TBL] [Abstract][Full Text] [Related]
15. Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation.
Lin T; Pajarinen J; Kohno Y; Huang JF; Maruyama M; Romero-Lopez M; Nathan K; Yao Z; Goodman SB
FASEB J; 2019 Mar; 33(3):4203-4211. PubMed ID: 30521384
[TBL] [Abstract][Full Text] [Related]
16. IFNγ and TNFα synergistically induce apoptosis of mesenchymal stem/stromal cells via the induction of nitric oxide.
Li X; Shang B; Li YN; Shi Y; Shao C
Stem Cell Res Ther; 2019 Jan; 10(1):18. PubMed ID: 30635041
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells as immunomodulators after liver transplantation.
Popp FC; Renner P; Eggenhofer E; Slowik P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
Liver Transpl; 2009 Oct; 15(10):1192-8. PubMed ID: 19790154
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effects of interferon-γ on human fetal cardiac mesenchymal stromal cells.
Grinnemo KH; Löfling M; Nathanson L; Baumgartner R; Ketelhuth DFJ; Beljanski V; Davies LC; Österholm C
Stem Cell Res Ther; 2019 Dec; 10(1):371. PubMed ID: 31801632
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells and inflammatory lung diseases.
Iyer SS; Co C; Rojas M
Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
